Empirical treatment and mortality in bacteremia due to extended spectrum β-lactamase producing Enterobacterales (ESβL-E), a retrospective cross-sectional study in a tertiary referral hospital from Colombia.

In our study, 51% (n = 17/33) of the patients who had an IDC had appropriate empirical antibiotic treatment with carbapenems, compared to 35% (n = 27/71) in the group of patients that did not have an IDC; however, this difference did not reach statistical significance (P = 0.195, OR 0.57, 95% CI 0.25–1.33).

also in 111,027 other papers